Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 10433 - 10440 of 11439 results
The GMO Controversy Continues to Swirl
July 5, 2013| Blog| Viewpoint
Chinese Detain Pharmaceutical Company Managers in Economic Crime Probe
July 5, 2013| Blog| Viewpoint
The Impact of the Supreme Court’s DOMA Decision on Employee Benefit Plans — Some Certainty, Many Unanswered Questions
July 3, 2013| Advisory| Viewpoint
The Obamacare Delays and the Massachusetts "Fair Share" Employer Mandate: Now What?
July 3, 2013| Blog| Viewpoint
Senate Confirms Two New CPSC Commissioners—What it Means for Them, You, and CPSC
July 3, 2013| Blog| Viewpoint
Chancellor Strine Issues Important Decision Validating Board Adoption of Forum Selection Clause in Bylaws
July 3, 2013| Alert| Viewpoint
International Trade Commission Takes Steps to Promote Early Adjudication of Dispositive Issues
July 3, 2013| Alert| Viewpoint
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.